AKT1 and hepatocellular carcinoma: This suggests that the increased expression of PDE7B, as a potential oncogene, may inhibit the EMT process of hepatocellular carcinoma cells by suppressing the PI3K-AKT pathway, and thus play a tumor-suppressive role.